Colchicine/Statins for the Prevention of COVID-19 Complications (COLSTAT) Trial
Condition: SARS-CoV-2 Intervention: Drug: Standard of Care (SOC) and Colchicine+Rosuvastatin Sponsor: Yale University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cholesterol | Colchicine | Colcrys | COVID-19 | Crestor | Research | Rosuvastatin | SARS | Statin Therapy